Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1268 in its ...

Zydus Wellness has launched VieMax, a new product in Complan’s range aimed at adult nutrition. Available in vanilla and ...

Zydus Wellness launches VieMax, an adult nutrition product targeting gut health, muscle strength, and immunity, exclusively ...

Patients with metastatic castration-sensitive prostate cancer are recommended to be treated with enzalutamide tablets.

Zydus Lifesciences share price trading maginally lower in the opening trade on October 3 despite the company received ...

Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide tablets, a generic prostate cancer treatment drug, for ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration ...

Zydus Lifesciences on Saturday said it has received approval from the US health regulator to produce generic prostate cancer ...

Tarun Arora, CEO, Zydus Wellness, said, “VieMax is a perfect complement to our existing portfolio at Complan. For more than 50 years, Complan has been synonymous with family nut ...

A collaborative research agreement was inked between the parties to develop oral medication through the discovery of small ...